Surrozen, Inc. Common (SRZN) Stock: Buy, Sell, or Hold?
SRZN - Surrozen, Inc. Common
$19.00
-0.45 (-2.31%)
▼
5d:
-15.71%
30d:
-21.46%
90d:
-18.7%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When SRZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SRZN is down 15.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SRZN is down 15.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SRZN is currently trading at $19.00, which is considered oversold relative to its 30-day fair value range of $21.28 to $24.52.
Technical Outlook: Technically, SRZN is in a strong downtrend. Immediate support is located at $18.40, while resistance sits at $23.75.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $44.80 (+135.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRZN is in a strong downtrend. Immediate support is located at $18.40, while resistance sits at $23.75.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $44.80 (+135.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.28 -
$24.52
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 135.8% below Wall St target ($44.80)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$21.28 -
$24.52
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.40
Resistance Level
$23.75
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.54
Wall Street Target
$44.80
(+135.8%)
Revenue Growth (YoY)
408.6%
Earnings Growth (YoY)
-37.0%
Share & Embed Analysis
Last updated: September 12, 2026 11:07 PM ET
Data refreshes hourly during market hours. Next update: 12:07 AM
Data refreshes hourly during market hours. Next update: 12:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRZN showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tcg Crossover Gp Ii, Llc
BUY
106658 shares
2026-03-24
Tcg Crossover Gp Ii, Llc
BUY
15223 shares
2026-03-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 41 HOLD |
